Document is current
Any future updates will be listed below
-
Authors
Jiang, Ning
Yu, Yue
Wu, Dawei
Wang, Shuhang
Fang, Yuan
Miao, Huilei
Ma, Peiwen
Huang, Huiyao
Zhang, Min
Zhang, Yu
Tang, Yu https://orcid.org/0000-0002-7067-8066
Li, Ning
-
Funding
Funding for this research was provided by:
Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2021-I2M-1-045)
Beijing Hope Run Special Fund of Cancer Foundation of China (LC2021B11)
- License Information
-
More Information
Article History
Received: 13 March 2022
Accepted: 22 November 2022
First Online: 20 January 2023
Declarations
:
: Min Zhang is employed by Novogene Co., Ltd, Beijing, China. Yu Zhang is employed by Renke Beijing Biotechnology Co., Ltd, Beijing, China. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: This review involved no human or animal subject. Ethics approval is exempted.
: Not applicable.
: NO human subjects were involved in this review.
